Unfortunately, the very important findings from phase II and III studies from Argiris et al. [22,32] demonstrating the benefit achievable by VEGF targeting were not appropriately perceived by the community of HNSCC specialists. Here, VEGFA is linked to head and neck squamous cell carcinoma.